Frank Schaefer

Title: Frank Schaefer: Innovator in Pharmaceutical Chemistry

Introduction

Frank Schaefer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new crystalline forms of pharmaceutical compounds. His work has implications for the treatment of various medical conditions.

Latest Patents

Frank Schaefer holds a patent for the crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide. This compound, also known as ribociclib, is crucial in the formulation of pharmaceutical compositions. The patent outlines methods of treatment and production involving these new crystalline forms.

Career Highlights

Frank Schaefer is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development in the pharmaceutical sector, where he applies his expertise to innovate and improve drug formulations. His work has contributed to advancements in cancer treatment therapies.

Collaborations

Frank collaborates with esteemed colleagues such as Arnaud Grandeury and Nilesh Patel. Together, they work on various projects aimed at enhancing pharmaceutical efficacy and safety.

Conclusion

Frank Schaefer's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the field. His work continues to influence the development of effective treatments for patients worldwide.